Exhaled nitric oxide in patients with asthma: association with NOS1 genotype.

doi:10.1164/ajrccm.162.6.2003089

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Exhaled nitric oxide in patients with asthma: association with NOS1 genotype.

American journal of respiratory and critical care medicine - 1 Dec 2000

Wechsler M E, Grasemann H, Deykin A, Silverman E K, Yandava C N, Israel E, Wand M, Drazen J M

Abstract excerpt

An increased concentration of nitric oxide (NO) in exhaled air (FENO) is now recognized as a critical component of the asthmatic phenotype. When we identified patients with asthma on the basis of a standard case definition alone, we found that they were remarkably heterogeneous with respect to their FENO. However, when we included genotype at a prominent asthma candidate gene (i.e., NOS1) in the case definition,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asthma
Share to Cohort Studies
Share to DNA
Share to Nerve Tissue Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nitric Oxide

Share to Nitric Oxide Synthase

Share to Nitric Oxide Synthase Type I

Share to Statistics, Nonparametric

Source

Open in PubMed

Identifiers

PMID: 11112111
DOI: 10.1164/ajrccm.162.6.2003089

Genes

NOS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.